Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. - Matsuzawa, Fumihiko; Kamachi, Hirofumi; Mizukami, Tatsuzo; Einama, Takahiro; Kawamata, Futoshi; Fujii, Yuki; Fukai, Moto; Kobayashi, Nozomi; Hatanaka, Yutaka; Taketomi, Akinobu (BMC Cancer, 2021)